CLINICALONE LIMITED - LONDON
Company Profile | Company Filings |
Overview
CLINICALONE LIMITED is a Private Limited Company from LONDON UNITED KINGDOM and has the status: Active.
CLINICALONE LIMITED was incorporated 2 years ago on 20/05/2022 and has the registered number: 14120577. The accounts status is MICRO ENTITY and accounts are next due on 28/02/2025.
CLINICALONE LIMITED was incorporated 2 years ago on 20/05/2022 and has the registered number: 14120577. The accounts status is MICRO ENTITY and accounts are next due on 28/02/2025.
CLINICALONE LIMITED - LONDON
This company is listed in the following categories:
72200 - Research and experimental development on social sciences and humanities
72200 - Research and experimental development on social sciences and humanities
74909 - Other professional, scientific and technical activities n.e.c.
Accounts Status
Accounting Year End (d/m) | Accounts Last Made Up Date | Accounts Next Due Date |
---|---|---|
31 / 5 | 31/05/2023 | 28/02/2025 |
Registered Office
24 ORVILLE ROAD
LONDON
SW11 3LR
UNITED KINGDOM
This Company Originates in : United Kingdom
Confirmation Statements
Last Statement | Next Statement Due |
---|---|
19/05/2023 | 02/06/2024 |
Map
UNITED KINGDOM
Company Officers - Current and Previous
Name | Born | Nationality | Role | Appointed | Status |
---|---|---|---|---|---|
KARTHIGESU GAJENDRAN | Dec 1962 | British | Director | 2022-05-20 | CURRENT |
DR HITHANADURA ASITA DE SILVA | Aug 1962 | Sri Lankan | Director | 2022-07-01 | CURRENT |
Persons with Significant Control
Name | Active from | Born | Address | Level of control |
---|---|---|---|---|
Dr Hithandura Asita De Silva | 2022-07-14 | 8/1962 | London |
Ownership of shares 25 to 50 percent Voting rights 25 to 50 percent |
Mr Karthigesu Gajendran | 2022-05-20 | 12/1962 | London |
Ownership of shares 75 to 100 percent Voting rights 75 to 100 percent Right to appoint and remove directors |
Free Reports Available
Report | Date Filed | Date of Report | Assets |
---|---|---|---|
CLINICALONE LIMITED - Filleted accounts | 2024-01-13 | 31-05-2023 | £6,623 equity |